Microalgae, reimagined.

Towards a new era of algae fermentation.

What can our biotech platform deliver?

1. Bioactive ingredient sales

Golden carotenoid-rich microalgae powder being analysed in the PhycoFerm laboratory

From single ingredients to complete formulations – B2B.

We don’t just supply raw algae ingredients. We build formulations that combine bioactive algal compounds for targeted effects: gut health and antioxidant support for human nutrition, tailored blends for dietary supplements, nutrient-dense formulas for pet nutrition, and active compounds for cosmetic applications.

Best for: brands that want a nutrition partner, not just a supplier.

2. Strain and technology licensing

Erlenmeyer flasks of non-GMO Chlorella strains on a shaker, showing the yellow, white and green colour range

You manufacture.

We license.

 License a proprietary strain, a fermentation process, or both, and scale it in your facilities: exclusive rights, full technical transfer, and hands-on support to get your team producing at spec. You pay one upfront fee, plus a royalty tied to your success, with ongoing support as the partnership matures.

Best for: manufacturers and ingredient companies who want to scale production themselves.

3. Strain and technology services

Researcher holding a flask of white Chlorella culture beside green and yellow strains at PhycoFerm

Your target.

Our know-how.

You set the target, we hit it: higher DHA, greater protein content, richer pigment composition, better yield, increased stress tolerance, whatever the spec calls for. Fixed fee, fixed timeline, full technical handover, and you walk away owning complete commercial rights to what we deliver, no royalties, no strings attached.

Best for: companies needing a specific problem solved once, with full IP ownership.

How we're constantly improving our platform for sustainability:

Towards a more
regenerative process through
agro-industrial sidestreams

We’re moving fermentation feedstock away from conventional inputs and onto low-cost, agro-industrial carbon sources, like rice grits, potato starch, and molasses, that would otherwise go to waste. It’s frontier work in circular bioprocessing: a lower-cost, lower-impact way to grow the same strains at scale.

Towards smarter biomass fermentation through AI-powered process control

We’re building an AI-driven fermentation monitoring system that gives a live analytical read on every batch, going beyond what is standard in the industry. The aim is to hold batch-to-batch quality within a tight, specified range, so scaling up does not mean losing consistency or paying a premium for it.

Towards a new era
of algae cultivation,
sustainable by design.

Most microalgae are photoautotrophic: they need light and large open surfaces to grow, which limits how sustainably they can scale. We instead adapt strains to heterotrophic conditions, developing variants that grow on a carbon source in closed fermenters, making the process less resource-intensive than conventional cultivation.

Meet Our Team

Our dedicated team holds interdisciplinary, scientific, technical, financial and market-driven expertise.

Amikam Bar-Gil, PhD, Co-Founder and CEO of PhycoFerm, microalgae biotechnology company in Faro, Portugal
Amikam Bar-Gil, PhD
Co-Founder & CEO

Fundraising and investor relations, facility development

Benjamin Schmid, MSc, Co-Founder and COO of PhycoFerm, leading product and business development
Benjamin Schmid, MSc.
Co-Founder & COO

Product and business development,  
operational activities

Peter S. C. Schulze, PhD, Co-Founder and CTO of PhycoFerm, leading microalgae strain and bioprocess R&D
Peter S.C. Schulze, PhD​
Co-Founder & CTO​

R&D management, public funding acquisition, business development

Lisa M. Schüler, PhD, Chief Scientific Officer at PhycoFerm, specialising in fermentation and strain improvement
Lisa M. Schüler , PhD
CSO

Fermentation, strain improvement and bioprocessing

Nina Solyukova Schulze, MSc, Co-Founder and CFO of PhycoFerm, responsible for finance and administration
Nina Solyukova Schulze, MSc
Co-Founder & CFO

Administration, cash flow
management, tax strategy and optimisation

Tânia Palma, PhD, Scientist at PhycoFerm, working on bioprocess development and microbiology
Tânia Palma, PhD
Scientist

Bioprocess development, microbiology, environmental biotechnology

Redefining the future of nutrition via microalgae.

Microalgae hold answers to some of nutrition’s hardest problems, but only if they can be produced at scale without the cost and footprint of traditional cultivation. That’s the gap Phycoferm aims to close.


We’ve built a non-GMO, heterotrophic biomass fermentation platform, which can serve in various ways. The applications span human nutrition, dietary supplements, pet nutrition, and cosmetics. 
We’re building this with investors who want to be part of that shift. Reach out to us at info@phycoferm.com

Research and Innovation Projects

INNOVALG Project
FERMTECH Project
BIOCAP Project

Contact

PhycoFerm Lda.

Universidade do Algarve, Campus de Gambelas, Pavilhão B1, Gab. E6 (CRIA)
8005-139 Faro
Portugal

Drop Us A Message